Skip to main content
. 2009 Jul 1;297(3):R738–R743. doi: 10.1152/ajpregu.90889.2008

Fig. 4.

Fig. 4.

Moderate hyperbilirubinemia attenuates angiotensin II-induced cardiac hypertrophy. Mice were treated with Indinavir (500 mg·kg−1·day−1, oral gavage) for 3 days before the implantation of minipumps that delivered ANG II at 1 μg·kg−1·min−1. Hearts were harvested and weighed after 10 days of ANG II infusion; n = 7. P < 0.05 vs. control (*) and vs. ANG II (†).